Landos Biopharma (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- August 13, 2019
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Traction
- Completed Phase 1 clinical testing and initiated Phase 2 clinical testing of BT-11 for IBD.
- Founders
- Dr. Josep Bassaganya-Riera
- Company Description
- Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
- Market
- Autoimmune diseases
- Location
- Blacksburg, Virginia, USA
- Coinvestors
- Osage University Partners, PBM Capital Group, Perceptive Advisors, RTW Investments